Diabetes

Precision Medicine & Pharmacogenomics in Diabetes

Precision Medicine & Pharmacogenomics in Diabetes” will explore how advances in genomics, molecular biology, and data science are transforming the traditional one-size-fits-all approach into highly individualized strategies for diabetes diagnosis, treatment, and prevention. Precision medicine an emerging model of tailored healthcare takes into account genetic, environmental, and lifestyle factors that influence disease progression and drug response. In the context of diabetes, where the disease manifests in highly heterogeneous ways, such personalized approaches offer the potential for more effective and targeted interventions, improved therapeutic outcomes, and reduced risk of complications.Pharmacogenomics, a key pillar of precision medicine, studies how genetic variations affect an individual’s response to drugs. In diabetes care, this knowledge is being leveraged to guide medication selection, dosing, and treatment duration based on a patient’s unique genetic profile. . For example, genetic polymorphisms in drug-metabolizing enzymes (such as CYP2C9 or CYP2C8), drug transporters, and drug targets can significantly influence the efficacy and safety of commonly used diabetes medications such as sulfonylureas, metformin, thiazolidinediones, and DPP-4 inhibitors.